Risk-Sharing Drug Development Programs Experience Longer Development Times, According to the Tufts Center for the Study of Drug Development
May 08, 2014 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - May 8, 2014) - Drug development programs that involve several partners who share clinical development risks accounted for about half of all new therapeutic drug approvals...
Battelle Announces Third Annual CyberAuto Challenge
April 07, 2014 09:35 ET
|
Battelle
COLUMBUS, OH--(Marketwired - Apr 7, 2014) - Scores of students, engineers, scientists, policy leaders and white hat "hackers" will gather in Detroit this summer for the third annual Battelle...
Drug Developers Circumspect About Using Social Media in Clinical Research, According to the Tufts Center for the Study of Drug Development
March 06, 2014 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Mar 6, 2014) - Social media is gaining ground as an important tool to improve the clinical research process through more effective engagement of patient communities, but...
New ISR Report Identifies Why Forest Labs' Pipeline Is a Hot Topic
February 25, 2014 14:40 ET
|
Industry Standard Research
CARY, NC--(Marketwired - Feb 25, 2014) - Industry Standard Research (ISR) has announced the availability of a new report titled "Forest Labs Clinical Development Profile." This report provides...
New Breakthrough Therapy Designation Has Potential to Shorten Development Time Considerably, According to the Tufts Center for the Study of Drug Development
January 23, 2014 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Jan 23, 2014) - The recently launched Breakthrough Therapy Designation (BTD) program in the United States, aimed at expediting development and review of drugs intended to...
Drug Developers Are Implementing New Strategies for Use of Comparator Drugs in Clinical Trials, According to Tufts Center for the Study of Drug Development
January 16, 2014 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Jan 16, 2014) - Drug developers are aggressively implementing new strategies to improve their access to and use of comparator drugs, which are used in clinical trials to...
Drug Company Success Depends on New Development Paradigms, According to Tufts Center for the Study of Drug Development
January 07, 2014 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Jan 7, 2014) - While many drug developers continue to improve clinical trial operational efficiency to increase the pace of new product introductions, their medium- and...
Battelle-R&D Magazine Global Funding Forecast Predicts Cautious Growth for Research and Development Activity in 2014
December 09, 2013 08:18 ET
|
Battelle
COLUMBUS, OH--(Marketwired - Dec 9, 2013) - Global research and development (R&D) spending is forecast to grow by 3.8 percent -- or $60.0 billion -- to $1.6 trillion in 2014, according to...
Biotech Products in Big Pharma Clinical Pipelines Have Grown Dramatically According to the Tufts Center for the Study of Drug Development
November 14, 2013 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwired - Nov 14, 2013) - The pharmaceutical industry, especially Big Pharma, has dramatically shifted its R&D focus from its historical concentration on small molecule drugs...
Navitas Systems Announces Expansion of its Advanced Solutions Group and Receives State of Michigan Grant
October 23, 2013 14:07 ET
|
Navitas Systems
WOODRIDGE, Ill., Oct. 23, 2013 (GLOBE NEWSWIRE) -- Navitas Systems LLC (www.navitassys.com), a leading provider of energy-enabled system solutions, energy storage products, and power electronics for...